Nuo Therapeutics, Inc. (AURX)

Nuo Therapeutics Revenue

Nuo Therapeutics had revenue of $1.77M in the quarter ending June 30, 2026, with 152.64% growth. This brings the company's total for the last twelve months to $5.20M, up 166.61% year-over-year. In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth. That makes Nuo Therapeutics the 39,836th largest company in the world by revenue and 5,294th in the United States.

• Revenue (ttm): 5.20M
• Revenue Growth: +166.61%
• P/S Ratio: 12.11
• Revenue / Employee: 520.00K
• Employees: 10
• Market Cap: 62.48M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.31M	1.95M	142.72%
Dec 31, 2024	1.37M	756.65K	124.34%
Dec 31, 2023	608.53K	496.28K	442.12%
Dec 31, 2022	112.25K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error